申请人:Janssen Pharmaceutica NV
公开号:US20140364607A1
公开(公告)日:2014-12-11
Benzoimidazol-2-yl pyrimidines, purification methods for the same, and pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by H
4
receptor activity, including allergy, asthma, autoimmune diseases, and pruritus.
本文描述了苯并咪唑-2-基嘧啶类化合物、其纯化方法以及制备药物组合物和治疗由H4受体活性介导的疾病状态、障碍和病症的方法,包括过敏、哮喘、自身免疫性疾病和瘙痒症。